A short rundown of how retatrutide is built to act on GLP-1, GIP and glucagon receptors, and what those pathways may affect, like appetite and blood sugar.
Recap by typeshit. Post by Facebook on Facebook.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Photos online users uploaded mostly matched what they reported, but over 65% on compounded semaglutide or tirzepatide called it the brand version, Medscape reports.
A Facebook teaser on unregulated brain peptides sold with promises of sharper thinking and more output. Little detail beyond the hook.
Loading…